You are here: Home » Reuters » News
Business Standard

Novartis CEO Narasimhan remakes drugmaker's leadership as Wyss exits

Reuters  |  ZURICH 

By John Miller

ZURICH (Reuters) - Novartis's new is remaking the Swiss drugmaker's leadership as operations exits and three others including a and the company's top get executive committee seats.

Wyss, who was also Novartis's Swiss unit head, at since 1984 and was responsible for streamlining production and Narasimhan said in a statement on Monday that Wyss will be available to ensure a "proper handover".

Additionally, elevated three people to its executive committee: Steffen Lang, global head of technical operations; Shannon Klinger; and Bertrand Bodson, a hired last year to improve use of data in and development. [nL8N1LA1DU]

Narasimhan, who took over as in February, is emphasising the role of in helping come up with winning new therapies.

Last week, he announced plans to use a partner's mobile phone-based apps to create up to 10 drug trials, to reduce costs and speed recruitment of patients.

The elevation of Klinger, who has been chief ethics and compliance officer as well as head of litigation, comes as Novartis aims to bolster its reputation after a string of costly settlements and investigations over alleged bribery, including an ongoing probe in

(Editing by Michael Shields)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, March 12 2018. 12:53 IST